Evidence map›Paper›PMID 21536666›Full record

ArticleThe Journal of biological chemistry2011

Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.

Stephen D Farris, Jie Hong Hu, Ranjini Krishnan, Isaac Emery, Talyn Chu, Liang Du, Michal Kremen, Helén L Dichek, Elizabeth Gold, Stephen A Ramsey and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. S100 proteins in cardiovascular diseases.Molecular medicine (Cambridge, Mass.) · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Stephen D FarrisDepartment of Medicine, University of Washington, Seattle, Washington 98195, USA.
Jie Hong Hu
Ranjini Krishnan
Isaac Emery
Talyn Chu
Liang Du
Michal Kremen
Helén L Dichek
Elizabeth Gold
Stephen A Ramsey
David A Dichek
University of Washington · USInstitute for Systems Biology · US

Funding

CARDIOVASCULAR RESEARCH TRAINING PROGRAMT32HL007828 · NHLBI · UNIVERSITY OF WASHINGTON · PI Francis Kim, Farid Moussavi-Harami · 1997 to 2026
$10.2M
Mechanisms of Urokinase-induced Vascular DiseaseR01HL080597 · NHLBI · UNIVERSITY OF WASHINGTON · PI DICHEK, DAVID A · 2005 to 2009
$2.1M
Systems analysis of transcriptional interactions underlying foam cell formationK25HL098807 · NHLBI · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI RAMSEY, STEPHEN A. · 2010 to 2013
$584k
Howard Hughes Medical InstituteNHLBI NIH HHS K25 HL098807NHLBI NIH HHS K25HL098807NHLBI NIH HHS R01 HL080597NHLBI NIH HHS R01HL080597NHLBI NIH HHS T32HL07828
6 · The paper itself

Abstract

Data from clinical studies, cell culture, and animal models implicate the urokinase plasminogen activator (uPA)/uPA receptor (uPAR)/plasminogen system in the development of atherosclerosis and aneurysms. However, the mechanisms through which uPA/uPAR/plasminogen stimulate these diseases are not yet defined. We used genetically modified, atherosclerosis-prone mice, including mice with macrophage-specific uPA overexpression and mice genetically deficient in uPAR to elucidate mechanisms of uPA/uPAR/plasminogen-accelerated atherosclerosis and aneurysm formation. We found that macrophage-specific uPA overexpression accelerates atherosclerosis and causes aortic root dilation in fat-fed Ldlr(-/-) mice (as we previously reported in Apoe(-/-) mice). Macrophage-expressed uPA accelerates atherosclerosis by stimulation of lesion progression rather than initiation and causes disproportionate lipid accumulation in early lesions. uPA-accelerated atherosclerosis and aortic dilation are largely, if not completely, independent of uPAR. In the absence of uPA overexpression, however, uPAR contributes modestly to both atherosclerosis and aortic dilation. Microarray studies identified S100A8 and S100A9 mRNA as the most highly up-regulated transcripts in uPA-overexpressing macrophages; up-regulation of S100A9 protein in uPA-overexpressing macrophages was confirmed by Western blotting. S100A8/A9, which are atherogenic in mice and are expressed in human atherosclerotic plaques, are also up-regulated in the aortae of mice with uPA-overexpressing macrophages, and macrophage S100A9 mRNA is up-regulated by exposure of wild-type macrophages to medium from uPA-overexpressing macrophages. Macrophage microarray data suggest significant effects of uPA overexpression on cell migration and cell-matrix interactions. Our results confirm in a second animal model that macrophage-expressed uPA stimulates atherosclerosis and aortic dilation. They also reveal uPAR independence of these actions and implicate specific pathways in uPA/Plg-accelerated atherosclerosis and aneurysmal disease.

Indexed as

AnimalsAortaApolipoprotein A-IAtherosclerosisCalgranulin ACalgranulin BCoronary Artery DiseaseFemaleHumansLipid MetabolismMacrophagesMiceProtein Interaction MappingReceptors, ScavengerReceptors, Urokinase Plasminogen ActivatorRNA, MessengerApolipoprotein A-ICalgranulin ACalgranulin BReceptors, ScavengerReceptors, Urokinase Plasminogen ActivatorRNA, MessengerUrokinase-Type Plasminogen Activator

Identifiers

PMID21536666
PMCPMC3121410
OpenAlexW2122523542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.